13Nov
Covid–19 coronavirus: global merger review (updated 13 November 2020)
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). The table below reflects our understanding of the current effects on the merger review process in numerous jurisdictions around the world. It...
By:
Allen & Overy LLP
Related
On this episode of In-house Roundhouse, Rob DelPriore, Executive Vice President and General Counsel,...
Read More >
Private equity (PE) investment in physician groups has steadily grown over the last several years, w...
Read More >
On Friday, August 30, 2019, the California State Senate Appropriations Committee approved controvers...
Read More >
On May 21, 2020, the Securities and Exchange Commission (the SEC) announced the adoption of amendmen...
Read More >
HP has officially rejected Xerox’s enhanced takeover bid, again calling the offer “too low” and d...
Read More >
Employers, you see this movie all too often. You tolerate, and then ultimately discharge, a poor-per...
Read More >